+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Desmoid Tumors Market by Treatment Type (Anti-Hormonal Therapy, Chemotherapy, Cryoablation), Drug Type (OTC Drugs, Prescription Drugs), Tumor Location, End User, Age Group - Global Forecast 2025-2030- Product Image
Desmoid Tumors Market by Treatment Type (Anti-Hormonal Therapy, Chemotherapy, Cryoablation), Drug Type (OTC Drugs, Prescription Drugs), Tumor Location, End User, Age Group - Global Forecast 2025-2030- Product Image
Sale

Desmoid Tumors Market by Treatment Type (Anti-Hormonal Therapy, Chemotherapy, Cryoablation), Drug Type (OTC Drugs, Prescription Drugs), Tumor Location, End User, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083870
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Desmoid Tumors Market is undergoing substantial transformation, shaped by clinical complexity, evolving diagnostic approaches, and expanding therapeutic options. Senior decision-makers must navigate this dynamic environment with data-driven insights to ensure strategic advantage and continuity in patient care.

Market Snapshot: Desmoid Tumors Market Size and Growth

The desmoid tumors market grew from USD 2.68 billion in 2024 to USD 2.83 billion in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 3.79 billion by 2030. Accelerated innovation, emerging therapies, and global supply chain recalibrations continue to underpin growth trajectories in this sector.

Scope & Segmentation: Extensive Coverage of the Desmoid Tumors Market

This analysis delivers a comprehensive view of the desmoid tumors market, offering clarity on breadth and depth for investment and planning. Critical stakeholder perspectives, regional trends, and technological advancements are included for robust decision-making.

  • Treatment Types: Anti-hormonal therapies such as tamoxifen and toremifene, chemotherapy agents (e.g., doxorubicin regimens, methotrexate, vinblastine, pegylated liposomal doxorubicin), cryoablation, nonsteroidal anti-inflammatory drugs, radiation therapy, surgical procedures, targeted molecular interventions.
  • Drug Categories: Over-the-counter medications and prescription pharmaceuticals designed for disease stabilization, regression, or symptomatic relief.
  • Tumor Locations: Abdominal, extra-abdominal, and intra-abdominal tumors, each presenting unique therapeutic and clinical considerations.
  • End Users: Hospitals, ambulatory surgical centers, and specialty clinics committed to personalized patient pathways and efficient care delivery.
  • Age Groups: Adult, geriatric, and pediatric populations, with distinct monitoring and outcome requirements.
  • Regional Focus: Americas (including major US states and Latin America), Europe-Middle East-Africa (notable countries across Western Europe, Eastern Europe, and Africa), and Asia-Pacific (advanced and emerging markets covering major economies).
  • Key Players: Companies active in this space include Apotex Inc., Baxter International, Bayer AG, Bristol-Myers Squibb, Cipla, Dr Reddys Laboratories, Encapsula NanoSciences, Fermion Oy, Hetero Healthcare, Immunome, Intelicure Lifesciences, Iterion Therapeutics, Johnson & Johnson Services, Mayne Pharma, Medichem, Natco Pharma, Novartis AG, Pfizer, SpringWorks Therapeutics, Sun Pharmaceutical, Synthon International, and Teva Pharmaceutical Industries.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Molecular diagnostics and precision medicine are increasingly central in clinical decision-making, supporting informed therapeutic selection and risk assessment.
  • Multidisciplinary collaboration is now essential, with integrated teams of surgeons, oncologists, radiologists, and geneticists optimizing patient outcomes.
  • Market adoption is trending toward less invasive, multimodal therapies that balance disease control with quality-of-life outcomes for diverse patient populations.
  • Geographic variability in healthcare infrastructure and reimbursement creates nuanced access challenges, necessitating region-specific strategies and alignment with evolving payer expectations.
  • Technology adoption—especially in targeted therapy and advanced imaging—drives both competitive differentiation and value-based care models.
  • Industry partnerships, licensing agreements, and acquisitions foster accelerated time-to-market for novel agents and procedural innovations.

Tariff Impact: Navigating Pharmaceutical Supply Chain Disruptions

Recent US tariffs on pharmaceutical ingredients and medical devices have heightened costs and operational challenges for desmoid tumor therapies. Manufacturers are adapting through localized production, diversified supplier networks, and collaborative sourcing strategies, ensuring stability of drug availability. These changes amplify the operational complexity for procurement and regulatory compliance but can also lead to improved long-term resilience within supply chains.

Methodology & Data Sources

This report employs a rigorous mixed-method approach, combining primary interviews with clinicians and payers, extensive review of peer-reviewed literature, and robust statistical modeling. Expert validation and data triangulation establish actionable, high-confidence insights relevant to B2B stakeholders.

Why This Report Matters

  • Enables clear understanding of evolving desmoid tumor therapeutic landscapes, supporting competitive and regulatory strategy development.
  • Identifies actionable opportunities in biomarker research, supply chain adaptation, and value-based care innovation.

Leaders gain the data clarity needed for effective resource allocation, risk mitigation, and agile response to market changes within the desmoid tumors space.

Conclusion

This report empowers decision-makers with integrated insights, supporting effective strategies in a complex market. Advance planning, robust partnerships, and innovation alignment are keys to success in desmoid tumors management.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Efficacy and safety outcomes of gamma secretase inhibitors in desmoid tumor patients receiving long term treatment
5.2. Adoption of nirogacestat real world evidence data influencing treatment guidelines for aggressive fibromatosis management
5.3. Integration of biomarker profiling and genomic sequencing to personalize therapy selection in desmoid tumors
5.4. Emergence of patient reported outcome measures and quality of life endpoints in desmoid tumor clinical trials
5.5. Role of telemedicine and digital health platforms in facilitating multidisciplinary care coordination for desmoid tumor patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Desmoid Tumors Market, by Treatment Type
8.1. Introduction
8.2. Anti-Hormonal Therapy
8.2.1. Tamoxifen
8.2.2. Toremifene
8.3. Chemotherapy
8.3.1. Doxorubicin-based regimens
8.3.2. Methotrexate and Vinblastine
8.3.3. Pegylated liposomal doxorubicin
8.4. Cryoablation
8.5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
8.6. Radiation Therapy
8.7. Surgery
8.8. Targeted Therapy
9. Desmoid Tumors Market, by Drug Type
9.1. Introduction
9.2. OTC Drugs
9.3. Prescription Drugs
10. Desmoid Tumors Market, by Tumor Location
10.1. Introduction
10.2. Abdominal
10.3. Extra-Abdominal
10.4. Intra-Abdominal
11. Desmoid Tumors Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Desmoid Tumors Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Desmoid Tumors Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Desmoid Tumors Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Desmoid Tumors Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Apotex Inc.
16.3.2. Baxter International, Inc
16.3.3. Bayer AG
16.3.4. Bristol-Myers Squibb Company
16.3.5. Cipla Limited
16.3.6. Dr Reddys Laboratories Limited
16.3.7. Encapsula NanoSciences LLC
16.3.8. Fermion Oy by Orion Corporation
16.3.9. Hetero Healthcare Limited.
16.3.10. Immunome, Inc.
16.3.11. Intelicure Lifesciences
16.3.12. Iterion Therapeutics
16.3.13. Johnson & Johnson Services, Inc.
16.3.14. Mayne Pharma Group Limited
16.3.15. Medichem, S.A.
16.3.16. Natco Pharma Limited
16.3.17. Novartis AG
16.3.18. Pfizer Inc.
16.3.19. SpringWorks Therapeutics, Inc.
16.3.20. Sun Pharmaceutical Industries Limited
16.3.21. Synthon International Holding B.V.
16.3.22. Teva Pharmaceutical Industries Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DESMOID TUMORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DESMOID TUMORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DESMOID TUMORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DESMOID TUMORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DESMOID TUMORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DESMOID TUMORS MARKET: RESEARCHAI
FIGURE 26. DESMOID TUMORS MARKET: RESEARCHSTATISTICS
FIGURE 27. DESMOID TUMORS MARKET: RESEARCHCONTACTS
FIGURE 28. DESMOID TUMORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DESMOID TUMORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DESMOID TUMORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DESMOID TUMORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DESMOID TUMORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DESMOID TUMORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DESMOID TUMORS MARKET SIZE, BY TAMOXIFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DESMOID TUMORS MARKET SIZE, BY TAMOXIFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DESMOID TUMORS MARKET SIZE, BY TOREMIFENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DESMOID TUMORS MARKET SIZE, BY TOREMIFENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DESMOID TUMORS MARKET SIZE, BY DOXORUBICIN-BASED REGIMENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DESMOID TUMORS MARKET SIZE, BY DOXORUBICIN-BASED REGIMENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DESMOID TUMORS MARKET SIZE, BY METHOTREXATE AND VINBLASTINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DESMOID TUMORS MARKET SIZE, BY METHOTREXATE AND VINBLASTINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEGYLATED LIPOSOMAL DOXORUBICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEGYLATED LIPOSOMAL DOXORUBICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DESMOID TUMORS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DESMOID TUMORS MARKET SIZE, BY CRYOABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DESMOID TUMORS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DESMOID TUMORS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DESMOID TUMORS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DESMOID TUMORS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DESMOID TUMORS MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DESMOID TUMORS MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DESMOID TUMORS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DESMOID TUMORS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DESMOID TUMORS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DESMOID TUMORS MARKET SIZE, BY OTC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DESMOID TUMORS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DESMOID TUMORS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DESMOID TUMORS MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DESMOID TUMORS MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DESMOID TUMORS MARKET SIZE, BY EXTRA-ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DESMOID TUMORS MARKET SIZE, BY EXTRA-ABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DESMOID TUMORS MARKET SIZE, BY INTRA-ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DESMOID TUMORS MARKET SIZE, BY INTRA-ABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DESMOID TUMORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DESMOID TUMORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DESMOID TUMORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DESMOID TUMORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DESMOID TUMORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DESMOID TUMORS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DESMOID TUMORS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DESMOID TUMORS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DESMOID TUMORS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DESMOID TUMORS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DESMOID TUMORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES DESMOID TUMORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 104. CANADA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 105. CANADA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 106. CANADA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 107. CANADA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. CANADA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. MEXICO DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 119. MEXICO DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. MEXICO DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DESMOID TUMORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 187. GERMANY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 190. GERMANY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 191. GERMANY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 192. GERMANY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 193. GERMANY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. GERMANY DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. GERMANY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. FRANCE DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 204. FRANCE DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 205. FRANCE DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 206. FRANCE DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 207. FRANCE DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FRANCE DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. FRANCE DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. FRANCE DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. ITALY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 232. ITALY DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 233. ITALY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 234. ITALY DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 235. ITALY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. ITALY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ITALY DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ITALY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 242. ITALY DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 243. SPAIN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 246. SPAIN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 247. SPAIN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 248. SPAIN DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 249. SPAIN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SPAIN DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SPAIN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. SPAIN DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. DENMARK DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 302. DENMARK DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 303. DENMARK DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 304. DENMARK DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 305. DENMARK DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 306. DENMARK DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 307. DENMARK DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. DENMARK DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. DENMARK DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 312. DENMARK DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. QATAR DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 328. QATAR DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 329. QATAR DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 330. QATAR DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 331. QATAR DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 332. QATAR DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 333. QATAR DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 334. QATAR DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 335. QATAR DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 336. QATAR DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 337. QATAR DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. QATAR DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. QATAR DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 340. QATAR DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 341. FINLAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 342. FINLAND DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 343. FINLAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 344. FINLAND DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 345. FINLAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 346. FINLAND DESMOID TUMORS MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 347. FINLAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 348. FINLAND DESMOID TUMORS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 349. FINLAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2018-2024 (USD MILLION)
TABLE 350. FINLAND DESMOID TUMORS MARKET SIZE, BY TUMOR LOCATION, 2025-2030 (USD MILLION)
TABLE 351. FINLAND DESMOID TUMORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. FINLAND DESMOID TUMORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. FINLAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 354. FINLAND DESMOID TUMORS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN DESMOID TUMORS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 357. SWEDEN DESMOID TUMORS MARKET SIZE, BY ANTI-HORMONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 358. SWEDEN DESMOID TUMORS MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Desmoid Tumors market report include:
  • Apotex Inc.
  • Baxter International, Inc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr Reddys Laboratories Limited
  • Encapsula NanoSciences LLC
  • Fermion Oy by Orion Corporation
  • Hetero Healthcare Limited.
  • Immunome, Inc.
  • Intelicure Lifesciences
  • Iterion Therapeutics
  • Johnson & Johnson Services, Inc.
  • Mayne Pharma Group Limited
  • Medichem, S.A.
  • Natco Pharma Limited
  • Novartis AG
  • Pfizer Inc.
  • SpringWorks Therapeutics, Inc.
  • Sun Pharmaceutical Industries Limited
  • Synthon International Holding B.V.
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.79 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Desmoid Tumors - Global Strategic Business Report - Product Image

Desmoid Tumors - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Desmoid Tumors Market Report 2025 - Product Image

Desmoid Tumors Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Desmoid Tumors Drug Pipeline Analysis Report 2025 - Product Image

Desmoid Tumors Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2025 - Product Image

Desmoid Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Aggressive Fibromatosis Market by Treatment Type (Local Therapy, Systemic Therapy), End User (Ambulatory Surgical Center, Hospital, Specialty Clinic), Distribution Channel, Line of Therapy - Global Forecast 2025-2030 - Product Image

Aggressive Fibromatosis Market by Treatment Type (Local Therapy, Systemic Therapy), End User (Ambulatory Surgical Center, Hospital, Specialty Clinic), Distribution Channel, Line of Therapy - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.